A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia
- PMID: 24952892
- DOI: 10.1007/s12021-014-9235-4
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia
Abstract
[18F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely used diagnostic tool that can detect and quantify pathophysiology, as assessed through changes in cerebral glucose metabolism. [18F]-FDG PET scans can be analyzed using voxel-based statistical methods such as Statistical Parametric Mapping (SPM) that provide statistical maps of brain abnormalities in single patients. In order to perform SPM, a "spatial normalization" of an individual's PET scan is required to match a reference PET template. The PET template currently used for SPM normalization is based on [15O]-H2O images and does not resemble either the specific metabolic features of [18F]-FDG brain scans or the specific morphological characteristics of individual brains affected by neurodegeneration. Thus, our aim was to create a new [18F]-FDG PET aging and dementia-specific template for spatial normalization, based on images derived from both age-matched controls and patients. We hypothesized that this template would increase spatial normalization accuracy and thereby preserve crucial information for research and diagnostic purposes. We investigated the statistical sensitivity and registration accuracy of normalization procedures based on the standard and new template-at the single-subject and group level-independently for subjects with Mild Cognitive Impairment (MCI), probable Alzheimer's Disease (AD), Frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB). We found a significant statistical effect of the population-specific FDG template-based normalisation in key anatomical regions for each dementia subtype, suggesting that spatial normalization with the new template provides more accurate estimates of metabolic abnormalities for single-subject and group analysis, and therefore, a more effective diagnostic measure.
Similar articles
-
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.Neuroimage Clin. 2014 Dec 5;7:187-94. doi: 10.1016/j.nicl.2014.12.004. eCollection 2015. Neuroimage Clin. 2014. PMID: 25610780 Free PMC article.
-
Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls.Ann Nucl Med. 2013 Aug;27(7):600-9. doi: 10.1007/s12149-013-0723-7. Epub 2013 Apr 13. Ann Nucl Med. 2013. PMID: 23585159
-
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.Neuroimage Clin. 2023;39:103475. doi: 10.1016/j.nicl.2023.103475. Epub 2023 Jul 13. Neuroimage Clin. 2023. PMID: 37494757 Free PMC article.
-
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.J Alzheimers Dis. 2018;64(4):1175-1194. doi: 10.3233/JAD-171125. J Alzheimers Dis. 2018. PMID: 30010119 Free PMC article.
-
Brain fluorodeoxyglucose (FDG) PET in dementia.Ageing Res Rev. 2016 Sep;30:73-84. doi: 10.1016/j.arr.2016.02.003. Epub 2016 Feb 11. Ageing Res Rev. 2016. PMID: 26876244 Review.
Cited by
-
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins.J Neurol. 2015 Mar;262(3):642-7. doi: 10.1007/s00415-014-7619-x. Epub 2014 Dec 24. J Neurol. 2015. PMID: 25536905
-
Metabolic connectomics targeting brain pathology in dementia with Lewy bodies.J Cereb Blood Flow Metab. 2017 Apr;37(4):1311-1325. doi: 10.1177/0271678X16654497. Epub 2016 Jan 1. J Cereb Blood Flow Metab. 2017. PMID: 27306756 Free PMC article.
-
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.PLoS One. 2022 Apr 11;17(4):e0266906. doi: 10.1371/journal.pone.0266906. eCollection 2022. PLoS One. 2022. PMID: 35404966 Free PMC article.
-
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.Eur J Nucl Med Mol Imaging. 2019 May;46(5):1117-1131. doi: 10.1007/s00259-018-4246-2. Epub 2019 Jan 7. Eur J Nucl Med Mol Imaging. 2019. PMID: 30617963
-
Parkinson's Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism.Diagnostics (Basel). 2022 Dec 27;13(1):74. doi: 10.3390/diagnostics13010074. Diagnostics (Basel). 2022. PMID: 36611366 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical